What Is EmbryoGlue? Does It Really Boost IVF Implantation?

If you have been researching embryo transfer options, you have probably come across the term “EmbryoGlue” and wondered whether it is a genuine scientific advance or just a marketing label attached to a routine culture medium. It is a fair question. Add-ons in IVF are heavily promoted, sometimes with more enthusiasm than evidence behind them, and patients deserve a clear, honest answer rather than a sales pitch. Here is what EmbryoGlue actually is, how it is thought to work, and what the research really shows about its effect on implantation.

What Is EmbryoGlue?

EmbryoGlue is a specialised embryo transfer medium — the fluid an embryo is suspended in during the final minutes before it is placed into the uterus. Its defining ingredient is a high concentration of hyaluronan (hyaluronic acid), a naturally occurring molecule found in high levels in the fluid of the uterine cavity around the time of implantation. Standard transfer media contain little or no hyaluronan; EmbryoGlue is formulated to mimic the natural uterine environment more closely at the exact moment of transfer.

It is not a glue in the literal sense — it does not chemically bond the embryo to the uterine lining. The name refers to its proposed biological effect rather than any adhesive mechanism.

How EmbryoGlue Is Thought to Work

The theory behind EmbryoGlue rests on two main mechanisms:

• Hyaluronan receptors on the embryo. The outer cells of a blastocyst express CD44 and RHAMM receptors, which bind to hyaluronan. Laboratory studies suggest this binding may help the embryo adhere more readily to the endometrial surface.
• Increased medium viscosity. Hyaluronan makes the transfer fluid thicker. A more viscous medium may reduce the embryo’s expulsion from the uterine cavity and limit its movement immediately after transfer, in theory giving it a more stable environment to begin implanting.

Both mechanisms are biologically plausible and supported by laboratory and animal data, but plausibility is not the same as proven clinical benefit — which is why the human trial evidence matters more than the theory.

What the Evidence Actually Says

This is the part that gets glossed over in most marketing material, so it is worth stating plainly: the clinical evidence for EmbryoGlue is real but modest, and it is not consistent across every study.

A Cochrane systematic review of hyaluronan-enriched transfer media — the most rigorous type of evidence available, pooling data from multiple randomised controlled trials — found that hyaluronic acid–enriched media were associated with a higher rate of clinical pregnancy and live birth compared with standard media. The effect size, however, was modest, and the authors noted that the overall quality of evidence was limited by variability between studies, inconsistent reporting, and a signal that hyaluronan-enriched media may also be linked to a slightly higher rate of multiple pregnancy in some analyses — an outcome that is not automatically desirable in modern single-embryo-transfer practice.

In practical terms, most reviews put the improvement in implantation or clinical pregnancy rates in the range of a modest percentage-point increase per transfer, not a doubling or dramatic transformation of outcomes. Some individual trials show a clearer benefit than others, and the effect appears to vary by patient population — some studies suggest the benefit is more pronounced in women with a history of previous implantation failure, while in unselected, good-prognosis patients the difference from standard media is smaller and sometimes not statistically significant.

What the evidence does not support is any claim that EmbryoGlue reverses poor embryo quality, compensates for chromosomal abnormalities, or guarantees implantation. It is a supportive tool that may nudge the odds, not a solution that overrides the biology of the embryo or the uterine lining.

Who May Benefit Most

Based on the available trial data, EmbryoGlue is most often considered for:

• Patients with one or more previous failed embryo transfers despite good-quality embryos
• Women undergoing frozen embryo transfer cycles, where the medium can be incorporated without added procedural complexity
• Cases where the clinical team has no other clear explanation for prior implantation failure and wants to optimise every controllable variable

Is It Necessary for Everyone?

No — and any clinic implying otherwise is overstating the evidence. For patients undergoing a first embryo transfer with good-quality embryos and no history of implantation issues, standard transfer media already produce strong outcomes, and the marginal benefit of hyaluronan enrichment is smaller and less certain. EmbryoGlue is reasonably classified as a low-risk, evidence-informed adjunct rather than a mandatory step. It has an established safety profile — it is not associated with harm to the embryo or the patient — so the decision to use it is less about risk and more about whether the modest, statistically documented benefit is worth it for your specific situation.

At GynoLife IVF in Nicosia, Cyprus, our embryology team discusses transfer medium choices individually, based on your treatment history, embryo quality, and any prior transfer outcomes, rather than applying it as a blanket protocol for every patient.

Frequently Asked Questions

Does EmbryoGlue guarantee pregnancy?

No. No add-on can guarantee implantation or pregnancy. EmbryoGlue is associated with a modest improvement in clinical pregnancy rates in pooled trial data, but individual outcomes still depend primarily on embryo quality, endometrial receptivity, and maternal factors.

Is EmbryoGlue used for fresh or frozen transfers?

It can be used in both fresh and frozen embryo transfer cycles. It is simply the medium the embryo is loaded in immediately before transfer.

Does EmbryoGlue affect embryo grading or genetic testing?

No. It is used only at the transfer stage, after grading and any genetic testing (such as PGT-A) have already been completed.

Is EmbryoGlue safe?

Yes. Clinical trials and years of clinical use have not identified safety concerns for the embryo or the patient beyond the modest signal around multiple pregnancy rates, which is primarily managed through single embryo transfer practice.

Talk to Our Embryology Team

If you are weighing whether EmbryoGlue or other transfer-stage options make sense for your treatment plan, our embryologists at GynoLife IVF can walk you through your specific case — your embryo quality, transfer history, and realistic expectations — rather than a one-size-fits-all recommendation. Get in touch with our Nicosia-based team to discuss your next steps.